Bio-Techne Corp (TECH) key performance indicators and operating metrics (33 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Organic revenue growth | 3.00 percent | FY2026-Q4 |
| Protein Sciences organic revenue growth | 1.00 percent | FY2026-Q4 |
| Protein Sciences segment net sales | 231.2M | FY2026-Q4 |
| Diagnostics and Spatial Biology segment net sales | 90.1M | FY2026-Q4 |
| Adjusted diluted earnings per share | 0.52 USD_per_share | FY2026-Q4 |
| Adjusted gross margin | 69.20 percent | FY2026-Q4 |
| Adjusted EBITDA | 115.9M | FY2026-Q4 |
| Diagnostics and Spatial Biology organic revenue growth | 8.00 percent | FY2026-Q4 |
| Adjusted operating margin | 32.20 percent | FY2026-Q4 |
| Protein Sciences segment operating income | 100M | FY2026-Q3 |
| Diagnostics and Genomics segment operating income | 10.32M | FY2026-Q3 |
| Protein Sciences segment operating margin | 42.00 percent | FY2026-Q4 |
| Diagnostics and Spatial Biology segment operating margin | 11.20 percent | FY2026-Q4 |
| Adjusted operating income | 103.4M | FY2026-Q4 |
Back to TECH overview · TECH earnings · TECH holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.